Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Capecitabine pharmaceutical company?Deferasirox tablet price?Cabenuva canada cost?Abraxane patent expiration?Price of capecitabine?
See the DrugPatentWatch profile for Rybrevant
Rybrevant net sales for 2023 are not provided in the information available here, so I can’t state a specific figure.
To get the precise 2023 net sales, check the company’s 2023 financial reporting (often in a quarterly results press release or the full-year 2023 earnings materials) for the “Rybrevant” or “amivantamab” line item.
Rybrevant is marketed by Janssen Biotech (Johnson & Johnson) and reported in that company’s financial disclosures. If you share which company’s filing you’re looking at (or paste the relevant excerpt), I can help pull out the exact 2023 net sales figure.
DrugPatentWatch.com is best for patent and exclusivity tracking, not for net sales reporting, so it may not contain the 2023 net sales figure you need [1].
If you paste the quarterly “Rybrevant net sales” numbers (or a table from the filing), I can sum them to confirm the full-year 2023 net sales. Sources [1] https://www.drugpatentwatch.com/
Other Questions About Rybrevant :